INTRODUCTION
Formation of modified nucleotides in transfer RNA is an important part of the complex multistep maturation process which starts immediately after transcription of the corresponding gene by RNA polymerase III. In eukaryotic cells, the modification of nucleotides in tRNA begins in the nucleus and continues further in the cytoplasm. For those tRNAs that are transported into the cellular organelles, additional nucleotide modifications may also occur within these compartments (for review see 1,2). For those tRNA precursors that contain an intron, an additional maturation step consists in intron removal by a specific tRNA splicing machinery located in the inner part of the nuclear membrane, just before the tRNA is transported to the cytoplasm through the nuclear pore (for review see 3) . As a result, most nucleotide modifications in these intron-containing tRNAs occur before intron removal (4) (5) (6) . Since the presence of an intron may change significantly the folding and the 3D-architecture of the tRNA molecule, at least in the anticodon stem-loop region, one might expect that the formation of modified nucleotides, normally present in the anticodon stem-loop of fully matured tRNA molecules, may be influenced positively or negatively by the presence of an intron. Indeed, formation of several modified nucleotides, for example ψ 35 in eukaryotic tRNA Tyr (6) (7) (8) (9) (10) (11) , ψ 34 and ψ 36 in yeast tRNA Ile (12) and m 5 C 34 in yeast tRNA Leu (13) have been reported to be strictly intron dependent. On the other hand, enzymatic formation of several modified nucleotides, such as Gm 18 , Cm 32 , ψ 32 , Gm 34 , Q 34 , galQ 34 , m 1 G 37 , Y 37 , i 6 A 37 , Um 44 , was shown to be hindered by the presence of an intron and to take place only after intron excision (5, 7, (13) (14) (15) (16) (17) (18) , reviewed in (19) . Interestingly, the introduction of m 2 2 G at position 26 (20) or m 1 A at position 9 (Dr C.Florentz, personal communication) in certain tRNA molecules, seems to influence the folding pathway towards the correct cloverleaf tRNA structure. Thus, the observed stepwise addition of modified nucleotides may result in part from sequential structural reorganization of the 2D/3D conformation of the tRNA molecules during the complex maturation process (discussed in 21). [Symbols and common abbreviations of modified nucleotides are those of (22) . Universal numbering system for tRNA positions corresponds to that used in (23) .]
Fully matured yeast tRNA Phe (GAA) contains 14 modified nucleosides out of a total of 76 nucleotides (nt) (18.5%), respectively m 2 G 10 , D 16 , D 17 , m 2 2 G 26 , Cm 32 , Gm 34 , Y(Wybutosine) 37 , ψ 39 , m 5 C 40 , m 7 G 46 , m 5 C 49 , T 54 , ψ 55 and m 1 A 58 (23) (Fig. 1A) . The primary transcript of yeast tRNA Phe gene contains a 19 nt intron in the anticodon loop in addition to its 5′-and 3′-nucleotide extensions (24) (Fig. 1B) . The overall folding of precursor tRNA Phe in solution was studied by chemical and enzymatic probing (25) (26) (27) and by NMR (28) .
In the present work we used yeast tRNA Phe (anticodon GAA) as a model for studying, in detail, the relation between the presence of an intron and the sequential addition of modified nucleotides. To avoid the problems related to transcription of tRNA genes in vivo and to focus specifically on the tRNA maturation processes that involve splicing and nucleotide modifications, we used the yeast extract and T7 transcripts of synthetic tRNA Phe genes as substrates. Our data demonstrate that some modification reactions are negatively affected by the presence of the intron, the synthesis of many other modified nucleotides is not *To whom correspondence should be addressed. Tel: +33 1 69 82 34 98; Fax: +33 1 69 82 31 29; Email: yuri.motorin@lebs.cnrs-gif.fr
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors Figure 1 . Cloverleaf structures of naturally modified S.cerevisiae tRNA Phe (GAA) (A) and its intron-containing precursor (B). The numbering of positions in tRNA molecule as in (23) , abbreviations of modified bases as in (22) . Arrows (B) show the sites of excision of intron (shown in lower case letters). Thick bar in intron-containing tRNA (B) designates the anticodon (GAA).
influenced by the intron, while the enzymatic formation of m 5 C at position 40 in the anticodon stem is strictly dependent on the presence of the intron. Enzymatic formation of m 5 C 40 is independent of the whole architecture of the tRNA molecule and takes place on a minisubstrate composed of the anticodon stem and loop of yeast tRNA Phe prolonged by its natural 19 nt intron. These results demonstrate that the intron bears at least part of the recognition elements for methylation of cytosine-40.
MATERIALS AND METHODS

Chemicals and enzymes
α-32 P-radiolabelled nucleotide triphosphates (400 Ci/mmol) were from Amersham (UK). Tris, DTE and DTT, nucleoside triphosphates, Penicillium citricum nuclease P1, Aspergillus oryzae RNAse T2, phenylmethylsulfonylfluoride (PMSF) and spermidine were from Sigma (USA). Diisopropylfluorophosphate (DFP) and S-adenosyl-L-methionine (SAM) were from BoehringerMannheim (Germany). Bacteriophage T7 RNA polymerase and restriction enzymes were from MBI Fermentas (Vilnius, Lithuania), RNasin was from Promega (USA). Thin layer cellulose plates were from Schleicher & Schuell (Germany). Ultra pure ammonium sulphate was from BRL (USA). All other chemicals were from Merck Biochemicals (Germany).
Plasmids
The plasmids designated p67YF0 and pUC13Phe carrying respectively the synthetic gene of yeast tRNA Phe (anticodon GAA) (gift of Dr O.Uhlenbeck, Boulder, CO, USA) and of its intron-containing precursor (pre-tRNA Phe , gift of Dr J.Abelson, Pasadena, CA, USA) were both described in detail elsewhere (29) (30) (31) . The DNA template for T7 transcription of the introncontaining minisubstrate (anticodon stem-loop prolonged with the 19 nt long natural intron) was prepared by PCR amplification of the corresponding sequence present in the plasmid pUC13Phe using two oligonucleotides, respectively: TAATACGACTCACTATAgccagactgaagaaaaaac and TGGccagataacttgaccg (capital letters correspond to nucleotides of the T7 promoter in the first oligonucleotide and the half of the MvaI restriction site in the second oligonucleotide, while lower case letters in both oligonucleotides correspond respectively to sense 5′ end and antisense 3′ end nucleotides of the intron). The minisubstrate composed of the anticodon stem-loop of tRNA Phe was prepared by T7 transcription using synthetic double strand DNA template. PCR amplification and DNA fragment recovery were performed using standard techniques as described in (32) .
In vitro transcription of tRNA genes
Transcription was done using ∼1 µg of the MvaI linearized plasmid (2 pmol in the case of the DNA fragment corresponding to the PCR product of the stem-loop and intron) with 50-100 µCi (100 µM final) of one of the [α-32 P]NTP in 10 µl of reaction mixture containing 40 mM Tris-HCl, pH 7.9, 6 mM MgCl 2 , 10 mM DTE, 2 mM spermidine, 1 mM each of the other NTPs. The reaction was initiated by the addition of 20 U T7 RNA polymerase, followed by 2-3 h incubation at 37_C. The resulting runoff transcription product was purified by electrophoresis on a 6% denaturing PAAG and recovered as described elsewhere (18) .
Yeast S100 extract
The Saccharomyces cerevisiae strain PP1001 (αpep4-3, ade2, leu2; a gift from Dr K.Straby, University of Umea, Sweden) was grown overnight at 28_C in YPD liquid medium supplemented by 0.004% w/v adenine and 0.01% L-leucine. All of the following operations were carried out at 4_C. The cells were harvested by low speed centrifugation and resuspended in twice their weight of lysis buffer [50 mM Tris-HCl, pH 7.5, 100 mM KCl, 0.1 mM EDTA, 10 mM MgCl 2 , 10% glycerol, 10 mM β-mercaptoethanol, 1 mM phenylmethylsulfonylfluoride (PMSF), 1 mM diisopropylfluorophosphate (DFP)]. The frozen cell suspension was passed through a French Press at ∼4000-5000 p.s.i. and the resulting homogenate was centrifuged at 12 000 g for 20 min to remove cell debris (S10 extract). The supernatant was centrifuged for 20 min at 30 000 g (S30 extract) followed by 1 h at 100 000 g in a Beckman TL-100 ultracentrifuge. The resulting supernatant (S100 extract at ∼10-12 mg total protein/ml) was aliquoted and quickly frozen in liquid nitrogen. Aliquots were kept at -80_C until used.
Enzymatic assays
The standard reaction mixture for assaying the formation of modified nucleotides in tRNA transcripts was composed of 100 mM Tris-HCl, pH 8.0, 100 mM ammonium acetate, 5 mM MgCl 2 , 2 mM DTT, 0.1 mM EDTA, 20 µM SAM, 50-100 fmol (5-10 nM) of 32 P-labelled tRNA substrate in a final volume of 10 µl. Reaction was initiated by the addition of S100 yeast extract to a final concentration of ∼0.5-1.0 mg of total protein/ml. After incubation at 30_C, the reaction mixture was mixed with denaturing loading buffer, heated 2 min at 65_C and directly applied on 6% denaturing PAAG. The radioactive tRNA bands, as revealed by autoradiography of the gel, were eluted overnight, precipitated by ethanol and redissolved in appropriate buffer for further hydrolysis with nuclease P 1 (0.02 µg/µl) or RNAse T2 (0.01 U/µl) as described earlier (33) .
Analysis of modified nucleotides
Identification of the 32 P-labelled nucleotides in tRNA hydrolysates was performed by two-dimensional chromatography on thin layer cellulose plates. Two chromatographic systems were used: in both cases, the first dimension was developed with isobutyric acid:ammonia 25%:water (66:1:33/v:v:v), the while second dimension (in system 'N/R') was developed with 0.1 M sodium phosphate pH 6.8:solid ammonium sulphate:n-propanol or (system 'N/N') with 2-propanol:HCl 37%:water (68:17.6:14.4/v:v:v). Radioactive spots were quantified using a PhosphoImager instrument (Molecular Dynamics, USA) with integrated software ImageQuant. Calculations of molar amount of modified nucleotide per mol of tRNA substrate were done taking into account the nucleotide composition of tRNA transcript. The experimental error was estimated to be ∼0.05 mol/mol of tRNA. These errors were determined using the identically treated tRNA transcripts analyzed in triplicate.
RESULTS
Intron-containing yeast tRNA Phe is processed in yeast extract
The endonucleolytic degradation of 32 P-labelled T7 transcripts corresponding to intronless tRNA Phe (76 nt) and to end-mature, intron-containing pre-tRNA Phe (95 nt, see Fig. 1B ) were assayed in vitro, using undialyzed cell-free yeast extract (S10 or S100, see Materials and Methods). After various incubation periods, the reaction mixture was analyzed by gel electrophoresis. The results of Figure 2 indicate that the T7 transcript of intronless tRNA Phe (left part of figure) is stable, while under the same conditions, the intron-containing tRNA Phe (right part of figure) clearly undergoes a rapid endonucleolytic cleavage (estimated half-life 20 min). The sizes of the resulting cleavage products correspond to a mixture of two half molecules (37 and 39 nt) and to the intron (IVS of 19 nt). During the incubation, the two RNA halves become ligated again to produce the full length intronless tRNA Phe molecule (76 nt). This religation reaction is an ATP-dependent process (6, 34, 35) and, as expected, the yield of the religated tRNA molecule can be enhanced by the addition of extra ATP to the reaction mixture (data not shown). However, with the low amount of endogeneous ATP normally present in the non-dialyzed cell-free extract, the accumulation of the endonucleolytic 3′-and 5′-halves of the precursor tRNA Phe (splicing intermediates) and of the newly synthesized full-length tRNA Phe allowed to analyze easily the modification pattern of isolated oligonucleotides at the pre-and post-splicing steps of the in vitro tRNA Phe maturation (see below).
Not all modified nucleotides can be formed in intronless yeast tRNA Phe transcript
When the intronless tRNA Phe transcript, separately radiolabeled with each of the four NTPs, was incubated with S100 yeast extract in the presence of SAM as donor of methyl groups, several nucleotides were enzymatically modified. Figure 3A -D shows typical autoradiograms of 2D tlc analysis of radiolabeled modified nucleotides present in hydrolysates of tRNA transcript. Figure 4A and B shows the time course of formation of each of modified nucleotides, detected by such analysis. Nuclease P1 allowed to identify 5′-32 P-modified nucleotides, while RNase T2 allowed to identify those 3′-32 P-modified nucleotides that are 5′-adjacent to the 5′-[ 32 P]NTP used for transcription. Therefore, analysis of the P1 and T2 data for each series of four tRNA samples, separately radiolabelled with one of the four 5′-[ 32 P]NTP, allowed to check twice each position of the tRNA molecule for the presence of a given modified nucleotide.
The results indicate that nine out of 11 different kinds of modified nucleotides normally present in fully matured yeast tRNA Phe (Fig. 1A) were present in the hydrolysates of intronless tRNA Phe : they were m 2 GMP (arising from position 10), m 2 (36) . The lack or the instability of the necessary cofactors for Y 37 formation from m 1 G 37 in the S100 yeast extract may explain the absence of Y 37 in tRNA Phe . Alternatively, the Y 37 -forming enzymes might be unstable in vitro or depleted upon high speed centrifugation because of tight binding to the ribosomal fraction or to other high molecular mass entities. However, the later hypothesis can be ruled out since the use of freshly prepared S10, instead of S100 extract in the incubation mixture, did not catalyze Y 37 formation even in trace amounts (data not shown). Unexpectedly, the formation of m 1 A 58 was not detected in the tRNA transcripts incubated with S100 yeast extract. However, this modified nucleotide can be readily formed in vitro in several yeast tRNA transcripts (including intronless tRNA Phe ) upon incubation in a rat liver extract (data not shown) or after microinjection into the cytoplasm of Xenopus laevis oocytes (18,37 and unpublished results). Therefore, the absence of m 1 A 58 in both intronless tRNA Phe and its precursor (see below) must be due to some as yet undetermined properties of the corresponding yeast methylase and/or to inappropriate experimental conditions in vitro. As in the case of Y 37 formation, the absence of tight binding of tRNA:A 58 methylase to a high molecular mass entity was verified experimentally by testing of S10 yeast extract. Finally, only low amounts of the modified nucleotide D 17 , was detected (Fig. 3A) . Due to its migration on the tlc plate very close to the much more intense [ 32 P]UMP spot in both of the chromatographic systems used, this modified nucleotide is always difficult to detect and to quantify. Apparently no D 16 was formed since no DMP was detected in the T2-hydrolysate of UTP-labelled transcript. Essentially the same results as described above for the intronless tRNA Phe transcript (76 nt) were obtained for the religated tRNA Phe transcript (76 nt) after intron splicing and recovery. Figure 4B shows that almost 2 mol of pseudouridine per mol intronless tRNA Phe were formed after 10 min incubation. Identical results were obtained from the P1 hydrolysate of [ 32 P]UTP-labelled and from T2 hydrolysate of [ 32 P]CTPlabelled transcripts. This amount corresponds to the sum of ψ 39 and ψ 55 formation because to identical 3′-neighbouring cytosine (Fig. 1A) one cannot follow their formation separately. Enzymatic formation of Cm at position 32, m 1 G at position 37 and T at position 54 also occurred with high yields (Fig. 4A and  B) , while formation of m 2 2 G at position 26, Gm at position 34 and (Fig. 4A ) was reproducibly observed in several independent experiments and may indicate that some modified nucleotides should arise first at other sites before nucleotides at positions 34 and 46 can be enzymatically modified. Formation of D at position 17 (detected after T2 digestion of GTP-labelled tRNA) and m 5 C at position 49 (see below) occur only with low yields. As stated above, formation of Y 37 , m 1 A 58 and also D 16 (from T2 analysis of UTP labelled tRNA) were undetectable, even after prolonged incubation.
Modification patterns of intron containing tRNA Phe and intronless tRNA Phe transcripts are different
As shown in Figures 3 and 4 , several modified nucleotides present in hydrolysates of intronless tRNA Phe were not found in hydrolysates of intron-containing precursor tRNA Phe (Fig. 3 , compare A-D to E-H; Fig. 4 , compare A and B to C and D). These are CmMP derived from position 32, GmMP from position 34 and m 1 GMP from position 37, all located in the anticodon loop. The other modified nucleotides (m 2 GMP, m 2 2 GMP, ψMP, m 7 GMP, m 5 CMP and TMP), which occur in regions of the tRNA other than the anticodon loop, were present in both transcripts. Except for m 5 CMP, the time course of these 'intron-independent' nucleotide modifications are more or less the same (Fig. 4 , compare A and B to C and D). The case of m 5 CMP is noteworthy. Indeed, from T2 analysis of UTP-labelled transcripts, only 0.2 mol m 5 CMP per mol of intronless tRNA Phe was detected, while in the intron-containing tRNA Phe , the formation of 1.2 mol/mol m 5 CMP was observed. Because yeast tRNA contains m 5 C at positions 40 and 49 with a 3′-adjacent uridine in both cases, it was impossible to differentiate them using the nearest-neighbour method of analysis (Fig. 1A) . Taking into account that m 5 C 49 is frequently found in many yeast tRNAs, including those for which the corresponding genes do not contain an intron, the observed difference in m 5 C level is most probably related to the absence of C 40 methylation in intronless tRNA. A control test with tRNA Asp , which contains only m 5 C 49, showed a low yield of m 5 C formation in vitro (data not shown), as found in the case of intronless tRNA Phe .
Direct evidence for intron-dependent formation of m 5 C 40 comes from experiments with truncated precursor tRNA Phe . Using the PCR technique, a DNA fragment corresponding to the anticodon stem-loop, elongated with the natural intron and flanked on its 5′-end with a T7 promoter, was prepared. The corresponding runoff transcript (40 nt) was then transcribed in vitro, purified on PAAG and subsequently used as a 'minisubstrate' for the cytosine methylase present in S100 yeast extract. As shown in Figure 5G , this 40 nt minisubstrate was quantitatively modified to m 5 C; the rate of methylation of cytosine-i34 (which corresponds to C 40 in intronless tRNAs) was very similar to that observed for C 40 modification in intron-containing pre-tRNA Phe . Under identical experimental conditions, the control 22 nt RNA fragment, corresponding to the intronless anticodon stem and loop, remained completely unmodified (results not shown). Evidently, part of the identity elements required for tRNA recognition by the corresponding cytosine methylase are located within the 19 nt intron. Beside m 5 C 40 formation, no other modified nucleotides were detectable in the intron-containing minisubstrate, including ψ 39 5′-adjacent to the methylated C 40 (Fig. 5H) . Names of modified nucleotides are abbreviated as in (22); the number which follows each symbol corresponds to the position in tRNA. Numbering of the positions in tRNA as in (23) . Numbers in brackets correspond to the maximal yield of modification after 1 h incubation of tRNA transcript in S100 yeast extract at 30_C, as determined from the analysis of P1 or T2 digests by 2D tlc (as illustrated in Figs 3 and 4) . All values are given with approximation ± 0.05 mol/mol. Enzymatic formation of D 16 and m 1 A 58 was never detected. a The extent of G 10 modification varies much from one experiment to another. b ψ 39 and ψ 55 have the same neighbouring nucleotide and are thus indistinguishable by T2 analysis. However since 2 mol of ψ per mol tRNA were found, both positions were considered to be completely modified. The same situation occurs for m 5 C 40 and m 5 C 49 . In this case the value for m 5 C 40 formation was deduced from the difference between the value for intron-containing (1.2 mol/mol) and intronless (0.2 mol/mol) tRNA transcripts.
Modifications within the anticodon loop of tRNA Phe occur only when the intronless 5′-and 3′-halves are ligated
Accumulation of the two halves of tRNA molecules during incubation of intron containing tRNA Phe with yeast extract, as shown in Figure 2 (right half) , allowed us to analyze the modification pattern after the endonucleolytic reaction but before the ligation reaction. The results indicate that all except three modified nucleotides were present in the 3′-and 5′-halves, as compared to the results with religated 76 nt tRNA Phe ( Fig. 5E and F; see also Fig. 3A-D) . Only CmMP derived from position 32, GmMP from position 34 and m 1 GMP from position 37 in the anticodon loop were absent (Fig. 5C and D) , a situation which corresponds exactly to that described above for intron-containing tRNA Phe (Fig. 5 , compare C and D to A and B; see also Fig.  3E-H) . However, these missing modified bases were formed after religation of the two half molecules (37 + 39 nt) leading to the 76 nt yeast tRNA Phe (Fig. 5E and F ). These results demonstrate that the target nucleotides have to be in a loop structure in order to undergo the modification by the corresponding enzymes. On the other hand, none of these three modified nucleotides appeared when the 22 nt minisubstrate consisting of just the anticodon stem-loop was incubated in yeast extract (data not shown), which suggest that not only the anticodon loop but also the tRNA architecture is required for enzymatic 2′-O-methylation of the riboses at positions 32 and 34 and of the guanosine at position 37.
DISCUSSION
The choice of yeast tRNA Phe (GAA) to study the effect of intron removal on nucleotide modification pattern was made for several reasons. First, naturally occurring yeast tRNA Phe is rather extensively modified (14 out of 76 nt, 18.6%). Moreover among the modified nucleotides, D 16 (29, 30) . Third, the 3D-structure of naturally occurring yeast tRNA Phe (GAA) harbouring all the modified nucleotides, and also the 3D-architecture of the corresponding T7 transcripts (with or without intron, but lacking all the modified nucleotides) was extensively studied by chemical and enzymatic probing (25, 26, (38) (39) (40) (41) , NMR (28, (42) (43) (44) and, in the case of naturally occurring tRNA Phe , by X-ray crystallography at high resolution (45) . One aspect of yeast tRNA Phe that has not yet been explored in detail, is the problem of stepwise nucleotide modification. Figure 6 summarizes the results obtained for enzymatic formation of modified nucleotides when intronless tRNA Phe transcript (Fig. 6A) , intron-containing tRNA Phe transcript (Fig. 6B) , intron-containing minisubstrate (Fig. 6C ) and anticodon stem-loop fragment (Fig. 6D ) are incubated in a yeast extract. These results allow to divide the corresponding tRNA modification enzymes into three distinct groups ( Table 1) .
The first group of modification enzymes includes those that catalyze the modification reaction with equal efficiency in both intronless and intron-containing tRNA Phe precursor (m 2 G 10 , D 17 , m 2 2 G 26 , ψ 39 , m 7 G 46 , m 5 C 49 , T 54 and ψ 55 ) ( Table 1) . These modified nucleotides are found in many yeast tRNAs independently of the presence of an intron in the corresponding tRNA genes. As one can expect, most of these modifications (except ψ 39 ) are located outside the anticodon stem-loop. The fact that U 39 located at a proximal position to the anticodon loop can be converted to ψ 39 in both intron-containing tRNA Phe and intronless tRNA Phe , but not in the minisubstrates, implies that the corresponding pseudouridine synthase recognizes at least part of the tRNA architecture that is beyond the anticodon loop.
The second group of modification enzymes comprizes those which act only after intron removal (Cm 32 , Gm 34 and m 1 G 37 ). As expected, these modifications (middle column in Table 1 ) are present in the anticodon loop of tRNA. The fact that these modifications appear only after ligation of the two halves molecules implies that the corresponding enzymes recognize the sevenmembered anticodon loop of tRNA as identity element.
The third group of modification enzymes corresponds to those that are strictly intron-dependent. In the case of tRNA Phe only one enzyme of this type (tRNA methylase specific to m 5 C 40 ) participates in the maturation process at the precursor level. This enzyme also works on the minisubstrate composed of the tRNA Phe anticodon stem-loop elongated by the intron, thus demonstrating that only a limited structural domain, located within the prolongated anticodon stem-loop of the pre tRNA is necessary for recognition. This type of positive intron-dependence has already been demonstrated for formation of ψ 35 in tRNA Tyr of different origins (6-9,11), ψ 34 and ψ 36 in minor yeast tRNA Ile (12, 46) and m 5 C 34 in yeast tRNA Leu (13) . In all of these cases, the intron provides the transient RNA structure which bears the necessary identity elements for enzyme recognition (19) . This phenomenon may be similar to intron-dependent types of editing in GluB-receptor mRNA in rat brain (47, 48) and trans-guiding of 2′-O-methylations of eukaryotic rRNA by complementary snoRNAs (49, 50) . The case of m 5 C 34 formation in yeast tRNA Leu (13) is of special interest with regard to the present study. Indeed, as for the enzymatic formation of m 5 C 40 in yeast tRNA Phe , the target cytosine-34 in yeast tRNA Leu is found in a helical double-stranded RNA region transiently stabilized by the intron (27) . One might ask the question, therefore, whether the same enzyme in yeast catalyzes the methylation of cytosine at both position 34 in tRNA Leu and position 40 in tRNA Phe .
It is noteworthy that modified nucleotide m 5 C 40 was found only in tRNA specific for phenylalanine from fungi (S.cerevisiae and N.crassa) for which the corresponding genes contain an intron. All other eukaryotic tRNA Phe sequenced so far (including X.laevis tRNA Phe (51) have an unmodified cytosine or a pseudouridine at position 40; moreover the corresponding tRNA Phe genes have no intron (2) . Therefore, these eukaryotic cells may not contain the kind of RNA:cytosine methylase as we found in yeast. Indeed, when the intron-containing minisubstrate of yeast tRNA Phe was incubated in X.laevis S100 extract, no m 5 C formation was detected (data not shown). One exception seems to be tRNA Phe from the fungi S.pombe which was reported to contain m 5 C 40 (52) while the corresponding gene has no intron. However, reevaluation of the details of the sequence data published by these authors (52) , supports the view that in fact C 40 is probably not modified to m 5 C 40 in tRNA Phe from S.pombe. The possibility therefore exists that S.pombe also lacks the intron-dependent cytosine-40 methylase, as is the case for X.laevis oocytes.
Our results on the modification profile of pre-tRNA Phe in yeast are in good agreement with the earlier observations made in vivo for expressed synthetic genes of supressor tRNA Phe (19) . The absence of Cm 32 in the tRNA Phe precursor and the intron dependency of m 5 C formation was already suggested in that study, but in the latter case no distinction could be made between m 5 C at positions 40 and 49.
Last, but not least, the simple posttranscriptional methylation of cytosine-40 in anticodon arm of yeast tRNA Phe has been shown to facilitate a tight site-specific Mg 2+ binding which enables the anticodon stem-loop to form more than one conformation through a process regulated by Mg 2+ concentration (53,54, reviewed in 55) . This m 5 C-dependent, Mg 2+ -induced conformational changes of the anticodon stem-loop, in conjunction with the presence of other modified nucleotides in tRNA (m 1 G 37 , ψ 39 ), are important parameters for the biological function of the tRNA molecule, such as its recognition by aminoacyl-tRNA synthetases and codon reading on the ribosome during translation.
